ALBIGER, NORA MARIA ELVIRA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.217
AS - Asia 1.679
EU - Europa 1.011
AF - Africa 388
SA - Sud America 290
OC - Oceania 38
Continente sconosciuto - Info sul continente non disponibili 15
Totale 7.638
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.037
SG - Singapore 611
CN - Cina 385
BR - Brasile 172
VN - Vietnam 154
DE - Germania 138
HK - Hong Kong 136
IT - Italia 111
FI - Finlandia 92
SE - Svezia 80
GB - Regno Unito 70
UA - Ucraina 53
PL - Polonia 43
FR - Francia 38
NL - Olanda 36
BJ - Benin 32
IN - India 32
RU - Federazione Russa 31
AT - Austria 27
KR - Corea 25
AR - Argentina 23
IE - Irlanda 23
TR - Turchia 23
JP - Giappone 20
ZA - Sudafrica 20
CO - Colombia 19
MA - Marocco 19
CI - Costa d'Avorio 18
MX - Messico 18
BA - Bosnia-Erzegovina 17
PH - Filippine 17
AE - Emirati Arabi Uniti 16
ID - Indonesia 16
BZ - Belize 15
CA - Canada 15
GR - Grecia 15
JO - Giordania 15
BE - Belgio 14
BY - Bielorussia 14
CR - Costa Rica 14
ES - Italia 14
KH - Cambogia 14
NC - Nuova Caledonia 14
PE - Perù 14
PY - Paraguay 14
TH - Thailandia 14
UY - Uruguay 14
AL - Albania 13
DZ - Algeria 13
IL - Israele 13
MD - Moldavia 13
BB - Barbados 12
EC - Ecuador 12
GH - Ghana 12
GM - Gambi 12
MG - Madagascar 12
MK - Macedonia 12
PT - Portogallo 12
TZ - Tanzania 12
AF - Afghanistan, Repubblica islamica di 11
AZ - Azerbaigian 11
CH - Svizzera 11
KE - Kenya 11
LB - Libano 11
ME - Montenegro 11
SA - Arabia Saudita 11
BF - Burkina Faso 10
BW - Botswana 10
CZ - Repubblica Ceca 10
DJ - Gibuti 10
EE - Estonia 10
ET - Etiopia 10
HR - Croazia 10
IQ - Iraq 10
KG - Kirghizistan 10
LC - Santa Lucia 10
LV - Lettonia 10
NP - Nepal 10
PK - Pakistan 10
RE - Reunion 10
RO - Romania 10
RW - Ruanda 10
SO - Somalia 10
UZ - Uzbekistan 10
YT - Mayotte 10
ZM - Zambia 10
CD - Congo 9
CW - ???statistics.table.value.countryCode.CW??? 9
GT - Guatemala 9
HU - Ungheria 9
NI - Nicaragua 9
NO - Norvegia 9
NZ - Nuova Zelanda 9
PA - Panama 9
PS - Palestinian Territory 9
ZW - Zimbabwe 9
CV - Capo Verde 8
DK - Danimarca 8
DO - Repubblica Dominicana 8
HN - Honduras 8
Totale 7.299
Salva come PNG Salva come JPEG
Città #
Fairfield 571
Ashburn 440
Woodbridge 347
Singapore 340
Chandler 334
Ann Arbor 322
Houston 257
Seattle 212
Cambridge 207
Wilmington 187
Jacksonville 169
Beijing 133
Hong Kong 126
Boardman 70
Princeton 68
Santa Clara 65
Dong Ket 64
San Diego 50
Los Angeles 47
Des Moines 38
Helsinki 36
Munich 35
Cotonou 31
Ho Chi Minh City 31
Padova 29
Medford 28
Nanjing 28
Frankfurt am Main 26
Hefei 25
New York 24
Hanoi 22
Bytom 20
Roxbury 20
Abidjan 17
Seoul 16
Turku 15
Vienna 15
Amman 14
Buffalo 14
Phnom Penh 14
Noumea 13
Nuremberg 13
Accra 12
Dublin 12
Redondo Beach 12
São Paulo 12
Warsaw 12
Antananarivo 11
Athens 11
Belize City 11
Bridgetown 11
London 11
Milan 11
Tokyo 11
Djibouti 10
Johannesburg 10
Kigali 10
Lusaka 10
Montevideo 10
Nanchang 10
San José 10
Atlanta 9
Baku 9
Bishkek 9
Brooklyn 9
Castries 9
Guayaquil 9
Minsk 9
Nairobi 9
Ouagadougou 9
Riga 9
Tashkent 9
The Dalles 9
Zagreb 9
Asunción 8
Chennai 8
Chicago 8
Chisinau 8
Harare 8
Panama City 8
Podgorica 8
Shanghai 8
Willemstad 8
Abu Dhabi 7
Addis Ababa 7
Andorra la Vella 7
Auckland 7
Bangkok 7
Casablanca 7
Dakar 7
Dar es Salaam 7
Gaborone 7
Guatemala City 7
Istanbul 7
Jiaxing 7
Lima 7
Managua 7
Medellín 7
San Francisco 7
San Jose 7
Totale 5.048
Salva come PNG Salva come JPEG
Nome #
Paradoxical GH increase during OGTT is associated to first-generation somatostatin analogs responsiveness in acromegaly 271
Diagnosis and complications of Cushing's disease: gender-related differences. 241
An analysis of different therapeutic options in patients with Cushing's syndrome due to bilateral macronodular adrenal hyperplasia: A single-centre experience 225
Screening tests for cushing's syndrome: Urinary free cortisol role measured by LC-MS/MS 221
Early recognition of aggressive pituitary adenomas: a single-centre experience 218
Temozolomide cytoreductive treatment in a giant cabergoline-resistant prolactin-secreting pituitary neuroendocrine tumor 217
AHR over-expression in papillary thyroid carcinoma: clinical and molecular assessments in a series of Italian acromegalic patients with a long-term follow-up 216
Adrenal lesions in acromegaly: do metabolic aspects and aryl hydrocarbon receptor interacting protein gene have a role? Evaluation at baseline and after long-term follow-up. 203
Metyrapone treatment in Cushing’s syndrome: a real-life study 200
Daily salivary cortisol and cortisone rhythm in patients with adrenal incidentaloma 199
Second-line tests in the differential diagnosis of ACTH-dependent Cushing’s syndrome 196
A multicenter experience on the prevalence of ARMC5 mutations in patients with primary bilateral macronodular adrenal hyperplasia: from genetic characterization to clinical phenotype 194
Long-term glucocorticoid effect on bone mineral density in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency 194
Different therapeutic options in patients with Cushing's syndrome due to bilateral macronodular adrenal hyperplasia 184
A case of primary aldosteronism in pregnancy: do LH and GNRH receptors have a potential role in regulating aldosterone secretion? 183
The Role of Unilateral Adrenalectomy in ACTH-Independent Macronodular Adrenal Hyperplasia (AIMAH). 182
Combination therapy for Cushing's disease: effectiveness of two schedules of treatment. Should we start with cabergoline or ketoconazole? 182
Idiopathic primary hyperaldosteronism: normalization of plasma aldosterone after one month withdrawal of long-term therapy with aldosterone-receptor antagonist potassium canrenoate 181
Decrease in salivary cortisol levels after glucocorticoid dose reduction in patients with adrenal insufficiency: A prospective proof-of-concept study 180
Adrenal nodules in patients with Cushing's disease: prevalence, clinical significance and follow-up. 178
Allelic Variants of ARMC5 in Patients With Adrenal Incidentalomas and in Patients With Cushing's Syndrome Associated With Bilateral Adrenal Nodules 176
The glucose-dependent insulinotropic polypeptide receptor (GIPR) is overexpressed amongst GNAS1 mutation-negative somatotropinomas and drives GH-promoter activity in GH3 cells. 174
Cardiovascular autonomic dysfunction in patients with idiopathic diabetes insipidus 174
The R304X mutation of the Aryl hydrocarbon receptor Interacting Protein gene in familial isolated pituitary adenomas: mutational Hot-Spot or founder effect? 166
Therapeutic strategies for Cushing's syndrome: An update 162
Hypercortisolism and pregnancy upregulate von Willebrand factor through different mechanisms: report on a pregnant patient with Cushing's syndrome. 162
Prognostic factors in ectopic Cushing's syndrome due to neuroendocrine tumors: a multicenter study 160
Assessment of glucocorticoid therapy with salivary cortisol in secondary adrenal insufficiency. 160
Microsatellite (GT)(n) is part of the von Willebrand factor (VWF) promoter region that influences the glucocorticoid-induced increase in VWF in Cushing's syndrome. 159
Venous thromboembolism in patients with Cushing's syndrome: need of a careful investigation of the prothrombotic risk profile. 154
Predicting late recurrence in surgically-treated patients with Cushing's disease. 154
The GIP/GIPR axis is functionally linked to GH-secretion increase in a significant proportion of gsp(-) somatotropinomas 152
Thrombin generation in Cushing's Syndrome: do the conventional clotting indices tell the whole truth? 150
Effect of short term therapy with recombinant human growth hormone (GH) on metabolic parameters and preclinical atherosclerosis markers in hypopituitary patients with growth hormone deficiency. 145
The role of the size in thyroid cancer risk stratification 143
Patients with Cushing's syndrome have increased intimal media thickness at different vascular levels: comparison with a population matched for similar cardiovascular risk factors. 141
Adrenal morpho-functional alterations in patients with acromegaly. 135
The usefulness of combined biochemical tests in the diagnosis of Cushing's disease with negative pituitary magnetic resonance imaging 134
Haplotypes of Von Willebrand factor promoter predict thrombotic risk in Cushing's syndrome 128
Effect of protracted treatment with rosiglitazone, a PPARgamma agonist, in patients with Cushing's disease. 128
Cyclic Cushing's syndrome: an overview. 110
Peroxisome proliferator-activated receptor gamma in the human pituitary gland: expression and splicing pattern in adenomas versus normal pituitary. 109
Corticotropin-releasing hormone test predicts the outcome of unilateral adrenalectomy in primary bilateral macronodular adrenal hyperplasia 102
Aterosclerosi extra coronaria nella sindrome di Cushing 101
Sindrome di Cushing e rischio cardiovascolare 86
Utilità  dell'uso dei test (DDAVP, CRH e 8 MG DEX OVERNIGHT) nell'indicazione chirurgica e nell'outcome della malattia di Cushing 85
Totale 7.715
Salva come PNG Salva come JPEG
Categoria #
all - tutte 24.061
article - articoli 23.275
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 47.336
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021426 0 0 0 0 0 27 13 50 79 93 66 98
2021/2022685 14 73 82 52 63 48 18 87 28 15 63 142
2022/2023583 125 89 6 89 78 71 1 36 54 3 26 5
2023/2024267 5 39 33 14 31 30 36 12 5 7 26 29
2024/20251.101 5 50 66 56 162 33 38 85 96 47 181 282
2025/20262.469 205 391 574 752 454 93 0 0 0 0 0 0
Totale 7.715